Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
0.4030
-0.0340 (-7.78%)
At close: Mar 31, 2025, 4:00 PM
0.4051
+0.0020 (0.51%)
Pre-market: Apr 1, 2025, 5:34 AM EDT

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.

It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs.

Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings logo
Country United States
Founded 2005
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 66
CEO Scott Davis

Contact Details

Address:
101 Glacier Point, Suite A
San Rafael, California 94901
United States
Phone 510 984 1761
Website eksobionics.com

Stock Details

Ticker Symbol EKSO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001549084
CUSIP Number 282644301
ISIN Number US2826443010
SIC Code 3569

Key Executives

Name Position
Scott G. Davis Chief Executive Officer and Director
Jerome Wong Chief Financial Officer
Jason C. Jones Chief Operating Officer
Rachael Anderson Global Director of Marketing and Strategic Growth
Ann Cookson Human Resources Director
Foon Lim Chwee President of APAC
Stephan Aderhold Senior Vice President and GM of EMEA
Katherine Strausser Principal Controls Engineer

Latest SEC Filings

Date Type Title
Mar 31, 2025 PRE 14A Other preliminary proxy statements
Mar 17, 2025 8-K Current Report
Mar 3, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 3, 2025 10-K Annual Report
Mar 3, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A Filing
Feb 14, 2025 SCHEDULE 13G/A Filing
Jan 13, 2025 8-K Current Report
Dec 13, 2024 8-K Current Report
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals